Technical Analysis for FARN - Faron Pharmaceuticals Oy
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Doji - Bearish? | Reversal | 0.00% | |
| Multiple of Ten Bullish | Other | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | 6.25% | |
| Spinning Top | Other | 6.25% | |
| Oversold Stochastic | Weakness | 6.25% | |
| New 52 Week Closing Low | Bearish | 8.51% | |
| Lizard Bullish | Bullish Day Trade Setup | 8.51% | |
| Narrow Range Bar | Range Contraction | 8.51% | |
| Doji - Bullish? | Reversal | 8.51% |
| Alert | Time |
|---|---|
| Gap Down Closed | about 11 hours ago |
| Reversed from Down | about 11 hours ago |
| Gap Down Partially Closed | about 11 hours ago |
| Down 5% | about 12 hours ago |
| Down 3% | about 12 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Faron Pharmaceuticals Oy is a Finland-based biopharmaceutical company engaged in the biotechnology and medical research industry. The Company develops late stage clinical drugs focusing on acute organ traumas, cancer immunotherapy and vascular damage. Its product pipeline includes Traumakine (FP-1201-lyo), an Acute Respiratory Distress Syndrome (ARDS) treatment that is in phase Three development; and Clevegen (FP-1304), an anti-Clever-1 immunotheraphy tumor targeting candidate that is in pre-clinical stage development.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pharmaceutical Medicine Pharmaceuticals Cancer Pipe Branches Of Biology Medical Specialties Clinic Drugs Biopharmaceutical Targeting Therapy Respirator Tumor Medical Research Immunotherapy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pharmaceutical Medicine Pharmaceuticals Cancer Pipe Branches Of Biology Medical Specialties Clinic Drugs Biopharmaceutical Targeting Therapy Respirator Tumor Medical Research Immunotherapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 364.0 |
| 52 Week Low | 113.0 |
| Average Volume | 37,405 |
| 200-Day Moving Average | 258.20 |
| 50-Day Moving Average | 147.98 |
| 20-Day Moving Average | 130.33 |
| 10-Day Moving Average | 123.55 |
| Average True Range | 11.61 |
| RSI (14) | 41.86 |
| ADX | 28.47 |
| +DI | 16.12 |
| -DI | 26.28 |
| Chandelier Exit (Long, 3 ATRs) | 120.18 |
| Chandelier Exit (Short, 3 ATRs) | 147.82 |
| Upper Bollinger Bands | 147.29 |
| Lower Bollinger Band | 113.36 |
| Percent B (%b) | 0.42 |
| BandWidth | 26.03 |
| MACD Line | -9.28 |
| MACD Signal Line | -10.85 |
| MACD Histogram | 1.5655 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 138.75 | ||||
| Resistance 3 (R3) | 138.00 | 133.50 | 136.88 | ||
| Resistance 2 (R2) | 133.50 | 130.64 | 133.88 | 136.25 | |
| Resistance 1 (R1) | 130.50 | 128.87 | 131.25 | 131.25 | 135.62 |
| Pivot Point | 126.00 | 126.00 | 126.38 | 126.38 | 126.00 |
| Support 1 (S1) | 123.00 | 123.14 | 123.75 | 123.75 | 119.38 |
| Support 2 (S2) | 118.50 | 121.37 | 118.88 | 118.75 | |
| Support 3 (S3) | 115.50 | 118.50 | 118.13 | ||
| Support 4 (S4) | 116.25 |
